Low-dose spironolactone reduces plasma fibulin-1 levels in patients with type 2 diabetes and resistant hypertension (Q59489139)
Jump to navigation
Jump to search
scientific article published on 17 April 2014
Language | Label | Description | Also known as |
---|---|---|---|
English | Low-dose spironolactone reduces plasma fibulin-1 levels in patients with type 2 diabetes and resistant hypertension |
scientific article published on 17 April 2014 |
Statements
Low-dose spironolactone reduces plasma fibulin-1 levels in patients with type 2 diabetes and resistant hypertension (English)
C S Oxlund
C Cangemi
I A Jacobsen
J Gram
K Schousboe
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference